Hospira Recalls Magnesium Sulfate Injection Due to pH Issues
Hospira Inc. recalls Magnesium Sulfate Injection, USP 50%, 20mL vials due to failed pH specifications. Check lot numbers and expiration dates.
Recall notice
Failed pH Specifications: 12 month stability testing
Contact the company
What happened, in plain English
Hospira Inc. is recalling Magnesium Sulfate Injection, USP, 50%, 20mL single-dose fliptop vials because they failed pH specifications during stability testing. The affected product was manufactured for Hospira, Inc. and distributed nationwide in the U.S. as well as to Kuwait, Bahrain, and Israel. The recall covers approximately 106,900 vials. Read more at govinfonow.com/recall/44676-hospira-inc-recalls-magnesium-sulfate-injection-usp-50-20ml-single.
Source Summary by GovInfoNow · govinfonow.com/recall/44676-hospira-inc-recalls-magnesium-sulfate-injection-usp-50-20ml-single · Updated October 12, 2026 · FDA enforcement record: FDA #D-1232-2015
Cite this page
“Hospira Recalls Magnesium Sulfate Injection Due to pH Issues.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44676-hospira-inc-recalls-magnesium-sulfate-injection-usp-50-20ml-single. Based on FDA recall #D-1232-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1232-2015%22&limit=1).
Why it’s dangerous
The recalled vials failed pH specifications during 12-month stability testing. The record does not specify the exact health risks or injury mechanisms associated with this failure, so the potential danger level is unknown based on the provided information.
Who’s affected
Healthcare providers and patients who received Magnesium Sulfate Injection, USP, 50%, 20mL single-dose fliptop vials distributed in the U.S., Kuwait, Bahrain, and Israel. Specifically, those with lot number 39-569-DK expiring on 3/1/2016 are affected.
How to tell if you have this one
Look for Magnesium Sulfate Injection, USP, 50%, 20mL, Single dose Fliptop Vial. Check for NDC 0409-2168-02 and Lot # 39-569-DK with an expiration date of 3/1/2016. The product was manufactured by Hospira, Inc. in Rocky Mount, NC.
- Brand
Hospira- Category
Drug
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
FDA distribution: “U.S. Nationwide, Kuwait, Bahrain and Israel.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA terminated this recall 2.5 years after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1232-2015 (May 19, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1232-2015 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.